Kachnic, L. A., Winter, K., Suntharalingam, M., Ilson, D., Konski, A., Lloyd, S., McAvoy, S. A., Lad, T., Olowokure, O. G., Samson, P., Gore, E. M., Meyer, J. E., Videtic, G. M. M., Clump, D. A., Raben, A., Kayaleh, O., Barker, J., Haddock, M. G., Hopkins, J. O., & Bruner, D. W. (2024). Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. Quality of Life Research. https://doi.org/10.1007/s11136-024-03736-7